Feb 26 (Reuters) - HEALTH CANADA :
* HEALTH CANADA SAYS RANBAXY PHARMACEUTICALS CANADA IS RECALLING 6 LOTS OF ITS PRESCRIPTION RAN-METFORMIN DRUG FROM CANADIAN MARKET
* HEALTH CANADA SAYS RANBAXY PHARMACEUTICALS CANADA IDENTIFIED 2 LOTS WITH LEVELS OF NDMA ABOVE WHAT IS CONSIDERED ACCEPTABLE